Study guide
19.1 Documentation, Critical Values, Corrected Reports, and Public Health
ASCP Microbiology Technologist M ASCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience
2 Preanalytic: Collection and Transport
2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature
3 Preanalytic: Processing, Media, and Incubation
3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation
4 Preanalytic: Stains
4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange
5 Bacteriology: Blood and Bone Marrow
5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity
6 Bacteriology: CSF and Sterile Body Fluids
6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods
7 Bacteriology: Respiratory Tract
7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular
8 Bacteriology: Gastrointestinal Tract
8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity
9 Bacteriology: Skin, Soft Tissue, and Bone
9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms
10 Bacteriology: Genital Tract and Urine
10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation
11 Bacteriology: Identification Methods
11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing
12 Bacteriology: Antimicrobial Susceptibility and Resistance
12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers
13 Bacteriology: Resistance Screening and Select Agents
13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity
14 Mycobacteriology and Nocardia
14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy
15 Virology
15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening
16 Parasitology
16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods
17 Mycology
17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods
18 Serology
18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis
19 Laboratory Operations: Postanalytic Procedures and Quality
19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation
20 Laboratory Operations: Safety, Mathematics, and Instrumentation
20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation
19.1 Documentation, Critical Values, Corrected Reports, and Public Health
Key Takeaways Explain This Topic AI
Document who performed, reviewed, and released the result, what was reported, and the date and time; the LIS audit trail is part of the permanent record.
Call urgent microbiology results immediately—positive blood-culture Gram stain, CSF Gram stain, AFB smear, malaria smear, and sterile-site positives—obtain a read-back, and document the call.
Autoverification may fit validated negatives (some urine cultures or NAAT negatives); it is not appropriate for first-positive blood-culture stains, unusual isolates, or mixed sterile-site growth.
A corrected report retains the original result, states the correction and reason, and includes clinician notification when the change could affect care.
Reportable diseases such as TB, meningococcus, measles, STEC, and Salmonella go to infection control and public health per the state list; antibiogram construction and stewardship programs are SM-only.
Last updated: August 2026
19.1 Documentation, Critical Values, Corrected Reports, and Public Health
Quick Answer: Record who did what and when. Call urgent microbiology results—positive blood-culture Gram stain, CSF Gram stain, AFB smear, malaria smear, sterile-site positives—obtain a read-back, and document the call. Autoverify only when locked rules fit (some negatives); never autoverify a first-positive blood-culture stain. Corrected reports keep the original line, explain the change, and notify the clinician. Report TB, meningococcus, measles, STEC, Salmonella, and other notifiable conditions to infection control and public health. Antibiogram construction and antimicrobial stewardship programs are SM-only.
Official outline IV.A Postanalytic Procedures sits inside Domain IV, Laboratory Operations ( 10–15% of M). The content guideline revised 2025-09-25 tests documentation practices, urgent and critical value reporting, result review and autoverification, issuing corrected reports, and reporting to infection control/prevention and public health. IV.A.6 Preparation of antibiogram and IV.A.7 Antimicrobial stewardship are SM ONLY and are not M-tested. IV.F Laboratory Administration is entirely SM ONLY. This section is bench reporting, not management theory.
Documentation practices: who, what, when
A microbiology result is not finished when the colony is named. CLIA and accreditors treat the permanent record as part of the test. Capture who performed, reviewed, and released the work, what was reported (organism or stain morphology, method, comments, notifications), and when (date and time of testing and of release). Initials or an electronic signature on the worksheet or LIS action assign responsibility; a shared department stamp does not.
Document at the time of the work. Blood-culture Gram-stain logs, malaria smear worksheets, and AFB smear records are frequent exam settings because the verbal call and the LIS entry drift apart if someone charts at the end of the shift from memory.
- Element What to capture Exam trap
- Who Operator, reviewer, and the person who called a critical A shared bench stamp is not an identity
What Result, method, comments, and notifications "Bottle positive" without Gram morphology is an incomplete blood-culture call
- When Date and time of testing and of report or call A date without a time fails a critical-value audit
- Identity Two patient identifiers plus accession and source Source omitted changes the meaning of mixed flora
- Amendments Original plus correction Silently deleting the first line destroys the legal record
Use current, defensible organism names the clinician will recognize, and always keep the source with the name. Klebsiella pneumoniae in blood is not the same event as the same name in sputum. Do not back-date, white-out paper worksheets, or edit an LIS line so the first result vanishes. Those actions are not documentation; they are a missing corrected-report process.
Urgent and critical value reporting
The medical director defines the laboratory's critical and urgent list. In microbiology the list is built around results that change isolation or therapy now :
Positive blood-culture Gram stain — call the morphology on the first positive bottle; do not wait for a species name
- CSF Gram stain with organisms
- Positive AFB smear
- Malaria (or other blood-parasite) smear
Sterile-site positives on stain or significant culture (CSF, synovial, peritoneal, pleural, pericardial, vitreous, intraoperative tissue, bone marrow)
Other locally defined items such as cryptococcal antigen or a suspected select agent
The M action is the same for each: call the responsible licensed caregiver immediately , obtain a read-back , and document the recipient's name, the date and time, the exact information read, and that read-back occurred. Read-back exists because "I told the nurse" does not prove the morphology was heard as gram-negative diplococci rather than gram-positive cocci. Voicemail, a sticky note, and an unread inbox flag are not completed notification.
Do not delay a blood-culture Gram-stain call for MALDI, biochemicals, or susceptibility. The stain is the critical result; the name follows. Do not skip the call because it is 02:00, because the organism "looks like a contaminant," or because infection control will see an electronic banner in the morning. Contaminant interpretation is a documented comment after the call, not a reason to stay silent on a first-positive bottle.
Result review and autoverification
Result review is a second set of trained eyes, or a validated computer rule, before release. Manual review is the default for culture interpretation: mixed flora versus pathogen, stain–culture correlation, and an ID that matches the susceptibility pattern.
Autoverification releases a result without human review when predefined, locked, validated rules are met. Chemistry uses it heavily. Microbiology uses it narrowly . Appropriate examples, if the laboratory has validated them: a negative urine culture with no growth on standard media at the protocol time; some negative NAAT panels with valid internal controls; a negative blood-culture status after the full instrument protocol. Inappropriate examples: a first-positive blood-culture Gram stain , CSF or other sterile-site growth, unusual or highly pathogenic organisms, mixed cultures that need a judgment comment, AST profiles that contradict the identification, or any run whose QC failed .
Autoverification is not a staffing shortcut. If the rules are not documented and tied to in-control QC, the exam answer is manual review .
Issuing corrected reports
Issue a corrected report when a released result is wrong or incomplete in a way that could change care: misidentified organism, wrong patient identity, a pathogen found on a plate already reported as no growth, transcribed morphology, or an amended susceptibility interpretation.
Leave the original result visible in the permanent record.
Issue a corrected report that states the new result and that it is a correction, with the reason (further testing, clerical error, instrument correction).
Notify the ordering clinician when the change is clinically significant, and notify infection control if isolation or public-health action already used the first result.
Do not silently overwrite, delete, or "fix" the first line so the audit trail disappears.
A same-day add-on that was never released is an additional result, not a correction. A corrected patient identity is both a corrected report and an identity investigation (Chapter 2).
Infection control and public health
Infection prevention uses microbiology for isolation and outbreak control: new Mycobacterium tuberculosis complex, invasive Neisseria meningitidis , measles, influenza/RSV/SARS-CoV-2 per policy, Clostridioides difficile , locally defined MRSA/VRE/CRE, and clustered identical isolates. The laboratory's job is timely notification , not designing the isolation cart.
Public health reporting is required for notifiable diseases . State and territorial lists vary; the exam tests the concept and classic organisms, not a fifty-state table. Typical laboratory-reportable findings include M. tuberculosis complex, invasive N. meningitidis , measles, Shiga toxin–producing E. coli (STEC), Salmonella spp., and, in many jurisdictions, Shigella , Listeria , Legionella , Bordetella pertussis , N. gonorrhoeae , C. trachomatis , and syphilis. Select-agent suspects follow the Laboratory Response Network pathway (Chapter 13).
Report according to the current state or local list and the laboratory SOP , often at confirmed result and, for some diseases, at a defined presumptive result. Do not wait for susceptibility to report stool Salmonella . Do not treat a single-bottle contaminant coagulase-negative Staphylococcus as a notifiable disease. Do not study antibiogram construction or antimicrobial stewardship program design as M items—those are SM-only (IV.A.6 and IV.A.7) . Knowing that a carbapenem-resistant isolate may also be locally notifiable is an M reporting task; building the annual percent-susceptible table is not.
Exam traps
Waiting for a species name before calling a positive blood-culture Gram stain.
Documenting the call without a read-back .
Autoverifying a sterile-site positive.
Overwriting a wrong ID instead of a corrected report plus clinician notification .
Treating public-health lists as optional courtesy copies.
Drilling antibiogram worksheets as if they were M-tested.
Postanalytic operations are a high-yield slice of the 10–15% laboratory-operations domain. Drill call-and-document and corrected-report stems in the free ASCP M practice bank .